- PFE +0.46%
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Yahoo Finance · 24 hours ago
Open | 29.30 |
High | 29.73 |
Low | 29.17 |
Mkt Cap | 166.85B |
P/E (TTM) | N/A |
Div & Yield | 1.68 & 5.73% |
Prev. Close | 29.31 |
52 Wk. Low | 25.20 |
52 Wk. High | 40.37 |
Related stocks
American multinational pharmaceutical corporation
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 14.88B | 19.50% ▼ |
Net Income | 3.12B | 43.80% ▼ |
Diluted EPS | 0.82 | 43.40% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.45 | - |
Q1 2024 | $0.52 | $0.82 |
Q4 2023 | -$0.22 | $0.10 |
S&P 500^GSPC | 5,289.78+6.38 (+0.12%) |
Dow 30^DJI | 38,701.85+130.82 (+0.34%) |
Nasdaq^IXIC | 16,851.12+22.45 (+0.13%) |
MicroAlgo Inc.MLGO | 11.00+594.46% |
Walmart Inc.WMT | 66.49+1.01% |
Bitcoin USDBTC-USD | 70,417.19+1.95% |